Completed NA INTERVENTIONAL 1-arm NCT04641130

Clinical Validation Study in Allergic Conjunctivitis to Birch Pollen During Allergen Challenge in ALYATEC EEC

Validation and Reproducibility Study of the ALYATEC Allergen Exposure Chamber by Determining the Concentration of Birch Pollen Allergen Inducing Conjunctivitis in Subjects Allergic to Birch Pollen.

Sponsor: Alyatec

Conditions Allergic Conjunctivitis

Interventions Exposure to birch pollen in EEC

Updated 4 times since 2020 Last updated: Dec 14, 2020 Started: Jul 13, 2017 Primary completion: Aug 30, 2017 Completion: Sep 11, 2017

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A NA clinical study on Allergic Conjunctivitis, this trial is completed. The trial is conducted by Alyatec and has accumulated 4 data snapshots since 2017. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

4 versions recorded

Sep 2024 — Present [monthly]

Completed NA
Jul 2024 — Sep 2024 [monthly]

Completed NA
Jan 2021 — Jul 2024 [monthly]

Completed NA
Dec 2020 — Jan 2021 [monthly]

Completed NA

First recorded

Jul 2017

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Alyatec

Data source: Alyatec

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Strasbourg, France